A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells

被引:84
作者
Calimeri, T. [1 ,2 ]
Battista, E. [3 ,4 ]
Conforti, F. [5 ]
Neri, P. [1 ,2 ,6 ]
Di Martino, M. T. [1 ,2 ]
Rossi, M. [1 ,2 ]
Foresta, U. [1 ,2 ]
Piro, E. [7 ]
Ferrara, F. [8 ]
Amorosi, A. [5 ]
Bahlis, N. [6 ]
Anderson, K. C. [9 ,10 ]
Munshi, N. [9 ,10 ]
Tagliaferri, P. [1 ,2 ]
Causa, F. [3 ,4 ]
Tassone, P. [1 ,2 ]
机构
[1] Univ Magna Gracia, Dept Expt & Clin Med, Translat Med Oncol Unit, Catanzaro, Italy
[2] Tommaso Campanella Canc Ctr, Catanzaro, Italy
[3] Univ Magna Gracia, Dept Expt & Clin Med, Biomat Lab, Catanzaro, Italy
[4] Italian Inst Technol, Ctr Adv Biomat Hlth Care, Naples, Italy
[5] Univ Magna Gracia, Dept Pathol, Sch Med, Catanzaro, Italy
[6] Univ Calgary, Dept Med, Hematol Unit, Calgary, AB, Canada
[7] Azienda Osped Pugliese Ciaccio, Hematol Unit, Catanzaro, Italy
[8] Villa Serena Hosp, Orthoped Surg Unit, Catanzaro, Italy
[9] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[10] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1038/leu.2010.300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:707 / 711
页数:5
相关论文
共 8 条
[1]   Poly-ε-caprolactone/hydroxyapatite composites for bone regeneration:: in vitro characterization and human osteoblast response [J].
Causa, F ;
Netti, PA ;
Ambrosio, L ;
Ciapetti, G ;
Baldini, N ;
Pagani, S ;
Martini, D ;
Giunti, A .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (01) :151-162
[2]   Synopsis of a roundtable on validating novel therapeutics for multiple myeloma [J].
Dalton, William ;
Anderson, Kenneth C. .
CLINICAL CANCER RESEARCH, 2006, 12 (22) :6603-6610
[3]   Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma [J].
Fulciniti, Mariateresa ;
Tassone, Pierfrancesco ;
Hideshima, Teru ;
Vallet, Sonia ;
Nanjappa, Puru ;
Ettenberg, Seth A. ;
Shen, Zhenxin ;
Patel, Nipun ;
Tai, Yu-tzu ;
Chauhan, Dharminder ;
Mitsiades, Constantine ;
Prabhala, Rao ;
Raje, Noopur ;
Anderson, Kenneth C. ;
Stover, David R. ;
Munshi, Nikhil C. .
BLOOD, 2009, 114 (02) :371-379
[4]   Drug therapy: Multiple myeloma [J].
Kyle, RA ;
Rajkumar, SV .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (18) :1860-1873
[5]   A clinically relevant SCID-hu in vivo model of human multiple myeloma [J].
Tassone, P ;
Neri, P ;
Carrasco, DR ;
Burger, R ;
Goldmacher, VS ;
Fram, R ;
Munshi, V ;
Shammas, MA ;
Catley, L ;
Jacob, GS ;
Venuta, S ;
Anderson, KC ;
Munshi, NC .
BLOOD, 2005, 106 (02) :713-716
[6]   Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: Experimental models and translational issues [J].
Tassone, Pierfrancesco ;
Tagliaferri, Pierosandro ;
Fulciniti, Maria Teresa ;
Di Martino, Maria Teresa ;
Venuta, Salvatore .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (05) :487-496
[7]   The development of a model for the homing of multiple myeloma cells to human bone marrow [J].
Urashima, M ;
Chen, BP ;
Chen, S ;
Pinkus, GS ;
Bronson, RT ;
Dedera, DA ;
Hoshi, Y ;
Teoh, G ;
Ogata, A ;
Treon, SP ;
Chauhan, D ;
Anderson, KC .
BLOOD, 1997, 90 (02) :754-765
[8]   Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations [J].
Yaccoby, S ;
Barlogie, B ;
Epstein, J .
BLOOD, 1998, 92 (08) :2908-2913